NEW YORK (GenomeWeb) – Illumina reported after the close of the market today that total fourth quarter 2014 revenues increased 32 percent year over year.

The San Diego-based company said that for the last three months of 2014, it took in $512.4 million in total revenues, up from $387.3 in the year ago quarter. Product revenues climbed 34 percent in the quarter to $450.3 million from $336.4 million in Q4 2013, while service revenue grew 22 percent to $62.1 million from $50.9 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.